Background: We identified erm(A)-harbouring Streptococcus pyogenes that expressed three variant phenotypes: (1) low-level resistance to erythromycin (MICs 1 -4 mg/L) but high azithromycin MICs in absolute terms (16 -64 mg/L; n 5 6); (2) same as (1) but with a high clindamycin MIC (256 mg/L; n 5 1); and (3) high-level constitutive MLS (cMLS) resistance (n 5 1). Here we analysed the genetic basis of these novel phenotypes.
Introduction
High efficacy and safety of macrolides have made them popular drugs for the treatment of pharyngitis and other infections caused by Streptococcus pyogenes. However, excessive macrolide use has been linked to the emergence and spread of macrolide-resistant strains. 1, 2 Macrolide resistance commonly occurs due to methylation of the macrolide-binding site on the ribosome by methyltransferases encoded by the erm group of genes. 3 Expression of the erm genes can be constitutive or inducible, depending on the sequence of the regulatory domain upstream of the structural gene. For instance, the erm(A) gene encodes an inducible methylase commonly present in Staphylococcus aureus and also reported in S. pyogenes.
Induction of erm(A) occurs by translational attenuation, in a manner similar to that of erm(C), the prototypic 'inducible' erm gene. 4 However, the erm(A) regulatory region is more complex and is composed of two leader peptides (LPs) as opposed to one for erm(C). erm(A) can be induced by the 14-membered ring (erythromycin) and 15-membered ring (azithromycin) macrolides, but not by the lincosamides (clindamycin) that share an overlapping ribosomal binding site with the macrolides. However, in vitro experiments show that clindamycin can easily select for alterations in the erm(A) regulatory region, resulting in a constitutive expression. 5 Nonetheless, clinical S. pyogenes harbouring constitutively expressed erm(A) have remained rare so far. 6 Moreover, in vitro-generated erm(C) LP mutants have been shown to exhibit variable efficiencies of induction with macrolides and lincosamides. 7 We report here erm(A)-harbouring S. pyogenes, isolated from skin and throat infections in Belgium and Italy, expressing divergent phenotypes where the role of erm(A) in mediating these phenotypes was further investigated.
Materials and methods
Strain collection and identification S. pyogenes isolated from skin and throat infections during national surveillance in Italy and Belgium were screened for macrolide resistance by phenotypic and genotypic methods. Isolates exhibiting phenotypic macrolide resistance by the conventional double-disc diffusion test with erythromycin and clindamycin were grouped into constitutive (cMLS), inducible (iMLS) and macrolide (M) phenotypes. MICs of erythromycin, spiramycin, clindamycin (Sigma-Aldrich, St Louis, MO, USA), clarithromycin (Abbott Ottignies, Belgium), azithromycin (Pfizer, Groton, USA) and telithromycin (Aventis, Romainville, France) were determined by agar dilution, and results were interpreted according to CLSI guidelines. 8 Macrolide-resistant S. pyogenes were investigated for the presence of erm(B), erm(A) and mef(A) by a previously described multiplex PCR protocol. 9 Screening for the cfr methyltransferase that confers resistance to clindamycin but not to macrolides in S. aureus was performed by PCR using primers FW (5 0 -TGTGACA TGGATACCAGCAG-3 0 ) and REV (5 0 -TCTTTTATGGGAAT GGG TGA-3 0 ). These investigations yielded eight macrolide-resistant erm(A)-harbouring S. pyogenes expressing variant phenotypes that were investigated further.
Alterations in erm(A) or in the macrolide-binding ribosomal sites
The entire erm(A) gene, including the regulatory region, was amplified from the eight variant isolates and from two erm(A)-harbouring S. pyogenes used as controls and exhibiting a 'normal' iMLS phenotype. Three sets of overlapping primers (sequences available on request) were designed based on the erm(TR) sequence (accession no. AF002716). PCR mix and cycling conditions were as described previously.
10 L4, L22 and portions of 23S rRNA genes (two parts of domain V and one of domain II) were amplified with known primers. 11 The amplified parts of domain V and domain II include regions where nucleotide modifications associated with erythromycin resistance have been described previously (G2057, A2058, A2062, G2505, C2611, A752 and A754, Escherichia coli numbering). PCR products were analysed by direct double-strand sequencing (3730 DNA Analyzer, Applied Biosystems, CA, USA), with the BigDye Terminator Version 3.1 Kit (Applied Biosystems). Nucleotide sequence alignment was performed using SeqMan (DNASTAR, Madison, WI, USA).
Cloning and transformation experiments
The entire erm(A) gene, including the regulatory region, from isolates IT1, IT2, B1, B2, B3 and one wild-type erm(A) control strain ( Table 1 ) was amplified ( primers on request) and cloned into pCR2.1, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). The recombinant plasmid was electroporated into competent E. coli AG100A (a kind gift from Patrice Courvalin), which is susceptible to macrolides due to disruption of the AcrAB pump, and selected on Luria-Bertani agar with ampicillin (50 mg/L) and azithromycin (4 mg/L). Phenotypic analysis (double-disc diffusion and MICs of erythromycin, clindamycin and azithromycin) and double-strand sequencing were performed on the transformants.
Typing of isolates
Clonality of the eight isolates was investigated by PFGE using SmaI, and the patterns generated were analysed by GelCompar software 4.0 (Applied Maths, Kortrijk, Belgium).
1 emm typing was performed by the method described on the CDC web site (http://www.cdc.gov/ncidod/biotech/strep/strepindex.html).
Secondary structure of erm(A)
Secondary structure predictions of the entire, wild-type erm(A) transcript in the uninduced state were made after comparisons with the erm(A) and erm(C) sequences in S. aureus using the DCSE tool. 12 Free energy changes (DG) were calculated using M-fold. 13 Drawings were performed using RnaViz 2.0. 14 
Results and discussion

erm(A)-harbouring S. pyogenes expressing variant phenotypes
Of the eight erm(A)-harbouring S. pyogenes studied, isolates IT1 to IT5 were clonal and exhibited a typical iMLS phenotype on double-disc diffusion with low-level resistance to erythromycin and susceptibility to clindamycin, although MICs of azithromycin were exceptionally high (16 mg/L) ( Table 1 ). Isolate B1 also showed an iMLS phenotype, although with intermediate resistance to clindamycin and high-level resistance to azithromycin (64 mg/L). Isolate B2 showed a novel phenotype (low-level resistance to erythromycin and high-level resistance to clindamycin), which presented as a shadow 'D' on double-disc diffusion with complete overgrowth in the clindamycin zone. This phenotype could be interpreted as a constitutive phenotype. 5 MICs of both azithromycin (32 mg/L) and clindamycin (256 mg/L) were high for isolate B2. Isolate B3 exhibited the constitutive phenotype with corresponding high MICs of all antibiotics tested (512 mg/L). All eight isolates showed point mutations in the erm(A) regulatory region (Table 1) . No additional macrolide/lincosamide resistance genes or mutations in the 23S rRNA genes or in the ribosomal proteins L4 or L22 were identified in these isolates.
Role of point mutations in the erm(A) regulatory region in mediating the variant phenotypes
Cloning and electrotransformation of the entire erm(A) gene from isolates IT1, IT2, B1 and B2 yielded E. coli AG100A transformants that expressed an iMLS phenotype similar to that observed with the wild-type erm(A) transformants. MICs of erythromycin, clindamycin and azithromycin for these transformants ranged from 4 to 8, 1 to 2, and 1 to 4 mg/L, respectively, indicating that the high-level resistance to azithromycin observed in isolates IT1-5, B1 and B2, and additionally to clindamycin in isolate B2, was not related to the G98A, A137C and C140T mutations present in the erm(A) regulatory region. In concordance, the role of these mutations in destabilizing the erm(A) secondary structure was also found to be minor (discussed subsequently). In contrast, E. coli AG100A transformed with erm(A) from isolate B3 and harbouring the A137C and G205A mutations expressed a constitutive MLS phenotype, which correlated with the observed impact of these mutations on the erm(A) secondary structure (discussed subsequently).
Conformational isomerization of the erm(A) regulatory region and influence of point mutations
Two thermodynamically probable conformations for the wildtype 211-base erm(A) regulatory region in the uninduced state were predicted, and hairpins made by segments 4 and 5, and 6 and 7 were supported by predictions at both energy levels (Figure 1a and b) . Neither structure can actively translate the methylase because the ribosome-binding site (SD3) and the initiation codon of erm(A) remain sequestered in both isomers. Induction of erm(A) begins in the presence of an inducing antibiotic by stalling of an antibiotic-bound ribosome in LP1, which frees the ribosome-binding site (SD2) of LP2. Further ribosomal stalling while translating LP2 destabilizes hairpin 6-7 and reconforms the regulatory region so that the initiation site of the erm(A) structural gene is available for an antibiotic-free ribosome to initiate methylase expression. Induction is regulated primarily by LP2 as deletion of LP1 renders the erm(A) regulatory region identical to that of erm(C) with no changes in inducibility. 7 Expectedly, the LP2 coding sequence is highly conserved across the erm(A) and erm(C) genes. In fact, our attempts to predict the structure of the entire wild-type, uninduced erm(A) transcript in S. pyogenes by a comparative analysis with erm(A) and erm(C) in S. aureus were unsuccessful specifically because the regions of LP2 [LP for erm(C)] and those before the erm initiation site were too highly conserved to permit any accurate structure predictions. As illustrated in Figure S1 [available as Supplementary data at JAC Online (http://jac.oxfordjournals. org/)], the conserved parts of the region ranging from the end of LP2 to the second codon of the methylase form a palindrome: sequence 6 and 7 is a repeat of 4 and 5 respectively which is also complementary. In the predicted structure for this region in erm(C) and for one of the structures for erm(A) in S. aureus, this palindrome forms one large hairpin by pairing 6 and 7 with 4 and 5 [ Figure S2 , parts A and C, available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)]. In erm(A) in S. pyogenes and in the second structure for erm(A) in S. aureus, another configuration is predicted, in which region 4 is paired with region 5, and 6 with 7 [ Figure 1 and Figure S2, part B] . Nonetheless, both these structures effectively sequester the start Table 1 . 
ORF of LP2 of the methylase. When region 4, which is part of the LP, is unavailable because of the stalling of the antibiotic-bound ribosome, a structure in which region 5 is paired with 6 is predicted for both erm(A) and erm(C). This structure is also supported by a compensating base change [C-G pair in erm(A) versus a U-A pair in erm(C)] ( Figure S1 , underlined in red). This structure leaves region 7 free and the gene unsequestered. Point mutations detected here in the erm(A) gene all mapped to the highly conserved bases either in LP2 or in the vicinity of SD3 (Figure 1 and Table 1) , and their role in mediating any free energy changes that might destabilize the erm(A) transcript was studied (Table 1) . 15 Free energy changes due to the A137C (Gln15Pro) and C140T (Pro16Leu) mutations were minor and probably insufficient to result in a stable conformation where the initiation sequence of the methylase is free, which is supported by the fact that E. coli transformed with mutant erm(A) genes from IT1, IT2, B1 and B2 expressed an iMLS phenotype. While the present study was ongoing, the C140T mutation was also reported independently in clinical erm(A)-harbouring S. pyogenes. 6 Free energy changes due to the additional G98A (Gly2Asn) mutation in isolate B2 were also minor ( Table 1) . Previous data also show that a substitution at Gly2 does not affect inducibility with erythromycin, 7 although its effect on induction with azithromycin or clindamycin remains unknown. In contrast, the G205A mutation in isolate B3 caused major changes in free energy (Table 1) . In vitro studies on constitutively expressed erm(C) in S. aureus have also shown that the C192-G205 [C171-G185 in erm(C)] base pair is critical for maintaining erm inducibility and, therefore, is a binary hotspot for mutations leading to a constitutive methylase expression. 15 Structure predictions of the erm(A) regulatory region in isolate B3, which exhibits a constitutive methylase expression, showed an abolishment of the hairpin 6 and 7 that released the initiation site of the erm(A) coding sequence (Figure 1c) . However, surprisingly, the G205A mutation does not seem to be solely responsible for this change; this mutation alone resulted in a massively destabilized (a change in DG from 213.4 kcal/mol for the wild-type to 27.3 kcal/mol for the G205A mutant) although intact hairpin 6-7. The additive effect of A137C, present in hairpin 4-5, and the G205A mutations together abolished hairpin 6-7.
In conclusion, our study identified point mutations in the erm(A) regulatory region leading to constitutive methylase expression and the presence of additional, as yet unidentified mechanisms mediating high-level azithromycin and clindamycin resistance in erm(A)-harbouring S. pyogenes.
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